SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences - Quaterly Results

28 Jan 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 3046.31 millions, about 6.09% up against Rs. 2871.31 millions recorded during the year-ago period.Profit saw a slight increase of 17.40%to Rs. 1040.55  millions from Rs. 886.34 millions.OP of the company witnessed a marginal growth to 1286.19 millions from 1067.73 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 3046.31 2871.31 6.09 9335.88 8519.85 9.58 11088.34 10202.31 8.68
Other Income 58.36 34.30 70.15 199.37 72.50 174.99 99.98 147.28 -32.12
PBIDT 1286.19 1067.73 20.46 4023.08 3305.44 21.71 4273.12 3703.28 15.39
Interest 7.65 1.65 363.64 20.14 5.79 247.84 7.78 18.54 -58.04
PBDT 1278.54 1066.08 19.93 4002.94 3299.65 21.31 4265.34 3684.74 15.76
Depreciation 135.37 92.37 46.55 363.85 275.02 32.30 376.40 448.82 -16.14
PBT 1143.17 973.71 17.40 3639.09 3024.63 20.32 3888.94 3235.92 20.18
TAX 102.62 87.37 17.45 334.26 212.06 57.63 382.89 323.18 18.48
Deferred Tax -128.29 -86.31 48.64 -394.50 -323.67 21.88 -318.95 -251.74 26.70
PAT 1040.55 886.34 17.40 3304.83 2812.57 17.50 3506.05 2912.74 20.37
Equity 135.93 135.78 0.11 135.93 135.78 0.11 135.78 135.78 0.00
PBIDTM(%) 42.22 37.19 13.54 43.09 38.80 11.07 38.54 36.30 6.17

Eris Lifesciences Share Price

1446.50 -18.90 (-1.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×